D26.776.708.645

5 trials

Sponsors

Universidade Federal de São Paulo - UNIFESP/EPM, Hospital Oftalmológico de Brasília, IPEPO - Instituto Paulista de Estudos e PEsquisas em Oftalmologia, Universidade Federal de São Paulo

Conditions

Glaucoma open angle Ocular hypertension Glaucoma suspectKeratitisOptic DoscPlasminogenPrimary open angle glaucoma

Phase 1

Treatment of ligneous conjunctivitis with platelet-rich plasma

RecruitingRBR-83cj4wn

Universidade Federal de São Paulo - UNIFESP/EPMPlasminogen

Start: 2024-04-03Updated: 2025-10-27

Phase 2

Relationship between IOP reduction and ocular blood perfusion

Active, not recruitingRBR-5hjbmtx

Hospital Oftalmológico de BrasíliaOptic Dosc

Start: 2021-08-01Updated: 2025-10-27

Corneal injury treatment protocol using 50% Autologous Serum Eye Drops

RecruitingRBR-34d3jv2

Universidade Federal de São Paulo - UNIFESP/EPMKeratitis

Start: 2023-09-01Updated: 2025-10-27

Phase 4

Evaluation of the use of Triplenex in Glaucoma: clinical trial

Active, not recruitingRBR-95qrz8g

Universidade Federal de São PauloPrimary open angle glaucoma

Start: 2021-03-01Updated: 2025-10-27

Unknown Phase

Clinical results using Latanoprost 0.005% (Xalatan®) compared to Latanoprost 0.005% (Arulatan®) eye drops in patients with glaucoma or ocular hypertension

Active, not recruitingRBR-82q4yf5

IPEPO - Instituto Paulista de Estudos e PEsquisas em OftalmologiaGlaucoma open angle Ocular hypertension Glaucoma suspect

Start: 2018-08-16Updated: 2025-10-27